Radnor Capital working with BenevolentAI
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery company listed on the Euronext Amsterdam stock exchange.
Radnor is retained by BenevolentAI to provide fully outsourced investor relations advisory ahead of its business combination with Odyssey Acquisition S.A. and upon completion of the transaction (April) as a listed company on the Euronext Amsterdam exchange.
Welcoming Holly Ha to the team
Holly’s passion and interest in corporate ESG responsibilities and reporting will be invaluable to Radnor, assisting our Client Directors in providing impactful and relevant advice to clients as they seek to navigate the increasingly complex and opaque ESG landscape. Holly is perfectly placed to make viable suggestions to boost ESG credentials based on their business operations, financial performance, impact and where they are in the corporate life cycle.